Year Established :
1957
Total Number of Staff :
100-500
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Production Capacity,Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages :
Competitive GMP quality system for APIs, approved by US FDA, TGA, COFEPRIS, with Chinese GMP. Five APIs have CEP certificate.
Business Type :
Manufacturer
R&D Capacity :
Own Brand
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Range :
Fluorouracil, Flucystosine, Phenylbutazone, Phenobarbital, Primidone, Piroxicam, Propylthiouracil, Tenoxicam